Quarterly report pursuant to Section 13 or 15(d)

8. Segment and Geographic Information

v2.4.0.8
8. Segment and Geographic Information
 9 Months Ended
Dec. 31, 2013
Segment Reporting [Abstract]  
8. Segment and Geographic Information

The Company generates revenues from tissue care products which are sold into the human and animal healthcare markets and the Company also generates revenues from laboratory testing services which are provided to medical device manufacturers. The Company operates a single segment business for product sales which consists of three geographical sales territories as follows:

 

    Three Months     Nine Months  
    Ended     Ended  
    December 31,     December 31,  
    2013     2012     2013     2012  
U.S.   $ 1,331,000     $ 1,653,000     $ 4,552,000     $ 5,584,000  
Mexico     1,237,000       1,356,000       4,013,000       4,596,000  
Europe and Other     511,000       348,000       1,521,000       1,257,000  
    $ 3,079,000     $ 3,357,000     $ 10,086,000     $ 11,437,000  

 

For the three months ended December 31, 2013 and 2012, the Company received licensing revenues of $629,000 and $702,000, respectively. Such revenues are included in the Company’s calculation of product revenues and are reflected in the table above under the respective geographic region where such licensing revenues were earned. For the nine months ended December 31, 2013 and 2012, the Company received licensing revenues of $1,459,000 and $1,125,000, respectively. Such revenues are included in the Company’s calculation of product revenues and are reflected in the table above under the respective geographic region where such licensing revenues were earned.

 

The Company’s service revenues amounted to $214,000 and $183,000 for the three months ended December 31, 2013 and 2012, respectively, and the Company’s service revenues amounted to $668,000 and $680,000 for the nine months ended December 31, 2013 and 2012, respectively.